ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SGMO Sangamo Therapeutics Inc

0.5101
0.0071 (1.41%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Sangamo Therapeutics Inc SGMO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0071 1.41% 0.5101 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.52 0.503 0.5339 0.5178 0.503
more quote information »

Recent News

Date Time Source Heading
4/22/202415:35BWSangamo Therapeutics to Present Neurology-Focused..
3/22/202407:05BWSangamo Therapeutics Announces Pricing of $24.0 Million..
3/13/202407:05BWSangamo Therapeutics Reports Recent Business Highlights and..
3/13/202407:01BWSangamo Therapeutics Announces Data From Novel Proprietary..
3/12/202417:30BWSangamo Therapeutics Announces Fourth Quarter and Full Year..
2/27/202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202416:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202416:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202416:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202407:05BWSangamo Therapeutics Announces U.S. FDA Alignment on..
2/06/202415:35EDGAR2Form 8-K - Current report
2/05/202417:01BWSangamo Therapeutics Announces Updated Phase 1/2 STAAR Study..
1/26/202410:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/24/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202416:09EDGAR2Form 8-K - Current report
12/13/202306:55EDGAR2Form 8-K - Current report
11/28/202315:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202315:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202315:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202315:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202315:02EDGAR2Form 8-K - Current report
11/01/202315:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/202315:02EDGAR2Form 8-K - Current report
11/01/202315:01BWSangamo Therapeutics Announces Strategic Update and Reports..
10/25/202315:15BWSangamo Therapeutics Announces Third Quarter 2023 Conference..
10/24/202301:01BWSangamo Therapeutics to Present Pre-Clinical Data Showcasing..
9/20/202315:15BWSangamo Therapeutics to Present at the Jefferies Cell &..
8/29/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/29/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/29/202315:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/29/202315:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/29/202315:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/29/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/15/202315:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/08/202315:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
8/08/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202315:08EDGAR2Form 8-K - Current report
8/08/202315:01BWSangamo Therapeutics Reports Recent Business Highlights and..
8/01/202315:15BWSangamo Therapeutics Announces Second Quarter 2023..
7/20/202307:05BWSangamo Therapeutics and Chroma Medicine Announce Option and..
7/17/202307:05BWSangamo Therapeutics Announces Research Evaluation and..
6/29/202307:05BWSangamo Therapeutics and Voyager Therapeutics Enter License..

Your Recent History

Delayed Upgrade Clock